XML 106 R96.htm IDEA: XBRL DOCUMENT v3.20.2
Reportable Segment Information - Summary of Financial Information for Each Reportable Segment (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Sep. 30, 2019
Segment Reporting Information [Line Items]          
Sales $ 574 $ 641 $ 1,717 $ 1,884  
OPERATING INCOME (LOSS) 48 43 (403) 80  
DEPRECIATION EXPENSE 41 40 120 160  
AMORTIZATION EXPENSE 21 22 63 65  
EBITDA [1],[2] 110 105 (216) 305  
TOTAL ASSETS 6,986   6,986   $ 7,251
Life Sciences [Member]          
Segment Reporting Information [Line Items]          
Sales 189 190 528 556  
OPERATING INCOME (LOSS) 40 32 97 88  
DEPRECIATION EXPENSE 8 8 24 24  
AMORTIZATION EXPENSE 7 7 21 21  
EBITDA [1],[2] 55 47 142 133  
TOTAL ASSETS 1,979   1,979   1,946
Personal Care & Household [Member]          
Segment Reporting Information [Line Items]          
Sales 155 158 451 495  
OPERATING INCOME (LOSS) 16 17 (309) 60  
DEPRECIATION EXPENSE 10 10 30 30  
AMORTIZATION EXPENSE 9 10 27 28  
EBITDA [1],[2] 35 37 (252) 118  
TOTAL ASSETS 979   979   1,366
Consumer Specialties [Member]          
Segment Reporting Information [Line Items]          
Sales 344 348 979 1,051  
OPERATING INCOME (LOSS) 56 49 (212) 148  
DEPRECIATION EXPENSE 18 18 54 54  
AMORTIZATION EXPENSE 16 17 48 49  
EBITDA [1],[2] 90 84 (110) 251  
TOTAL ASSETS 2,958   2,958   3,312
Specialty Additives [Member]          
Segment Reporting Information [Line Items]          
Sales 135 177 429 494  
OPERATING INCOME (LOSS) 15 19 (137) (5)  
DEPRECIATION EXPENSE 15 15 46 84  
AMORTIZATION EXPENSE 5 5 14 14  
EBITDA [1],[2] 35 39 (77) 93  
TOTAL ASSETS 1,642   1,642   1,775
Performance Adhesives [Member]          
Segment Reporting Information [Line Items]          
Sales 70 88 229 258  
OPERATING INCOME (LOSS) 13 16 40 42  
DEPRECIATION EXPENSE 4 4 10 11  
AMORTIZATION EXPENSE     1 1  
EBITDA [1],[2] 17 20 51 54  
TOTAL ASSETS 595   595   618
Industrial Specialties [Member]          
Segment Reporting Information [Line Items]          
Sales 205 265 658 752  
OPERATING INCOME (LOSS) 28 35 (97) 37  
DEPRECIATION EXPENSE 19 19 56 95  
AMORTIZATION EXPENSE 5 5 15 15  
EBITDA [1],[2] 52 59 (26) 147  
TOTAL ASSETS 2,237   2,237   2,393
Intermediates and Solvents [Member]          
Segment Reporting Information [Line Items]          
Sales 37 41 102 118  
OPERATING INCOME (LOSS) 7 8 (7) 20  
DEPRECIATION EXPENSE 4 3 10 8  
AMORTIZATION EXPENSE       1  
EBITDA [1],[2] 11 11 3 29  
TOTAL ASSETS 164   164   185
Intermediates and Solvents [Member] | Intersegment Eliminations          
Segment Reporting Information [Line Items]          
Sales [3] (12) (13) (22) (37)  
Unallocated and Other [Member]          
Segment Reporting Information [Line Items]          
OPERATING INCOME (LOSS) (43) (49) (87) (125)  
DEPRECIATION EXPENSE       3  
EBITDA [1],[2] (43) $ (49) (83) $ (122)  
TOTAL ASSETS $ 1,627   $ 1,627   $ 1,361
[1] Excludes income (loss) from discontinued operations, other net periodic benefit income (expense) and net income (loss) on divestitures. See the Statement of Consolidated Comprehensive Income (Loss) for applicable amounts excluded.
[2] Includes $39 million of accelerated depreciation for the nine months ended June 30, 2019.
[3] Intersegment sales from Intermediates and Solvents are accounted for at prices that approximate fair value. All other intersegment sales are accounted for at cost.